Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Revenues:
Premiums	$ 24,352	$ 21,631
Net investment income	334	168
Total revenues	85,278	76,826
Operating costs:
Cost of products sold	51,455	45,509
Benefit costs	20,448	17,923
Opioid litigation charge	0	484
Loss on assets held for sale	349	41
Operating expenses	9,580	9,324
Total operating costs	81,832	73,281
Operating income	3,446	3,545
Interest expense	589	586
Other income	(22)	(42)
Income before income tax provision	2,879	3,001
Income tax provision	737	646
Net income	2,142	2,355
Net income attributable to noncontrolling interests	(6)	(1)
Net income attributable to CVS Health	$ 2,136	$ 2,354
Net income per share attributable to CVS Health:
Basic (in dollars per share)	$ 1.66	$ 1.79
Diluted (in dollars per share)	$ 1.65	$ 1.77
Weighted average shares outstanding:
Basic (in shares)	1,283	1,312
Diluted (in shares)	1,291	1,328
Dividends declared per share (in dollars per share)	$ 0.605	$ 0.55
Cost, Product and Service [Extensible List]	Products	Products
Products
Revenues:
Revenues	$ 58,147	$ 52,522
Services
Revenues:
Revenues	$ 2,445	$ 2,505